|
TMEFF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63369995309637E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7166002780632E-10 |
| Normal-vs-Stage2 |
1.094630E-01 |
| Normal-vs-Stage3 |
2.53809999684051E-08 |
| Normal-vs-Stage4 |
1.0921999971103E-08 |
| Stage1-vs-Stage2 |
5.512200E-02 |
| Stage1-vs-Stage3 |
4.569800E-01 |
| Stage1-vs-Stage4 |
6.534100E-02 |
| Stage2-vs-Stage3 |
3.280100E-02 |
| Stage2-vs-Stage4 |
7.297700E-03 |
| Stage3-vs-Stage4 |
2.888200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46430000014242E-07 |
| Normal-vs-AfricanAmerican |
4.3866000000059E-05 |
| Normal-vs-Asian |
7.23159976345755E-10 |
| Caucasian-vs-AfricanAmerican |
4.285000E-01 |
| Caucasian-vs-Asian |
8.622400E-03 |
| AfricanAmerican-vs-Asian |
5.095000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53309999999718E-05 |
| Normal-vs-Female |
9.78800374085154E-11 |
| Male-vs-Female |
3.889400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.91159998730717E-09 |
| Normal-vs-Age(41-60Yrs) |
2.35760000411034E-08 |
| Normal-vs-Age(61-80Yrs) |
3.51739999999712E-05 |
| Normal-vs-Age(81-100Yrs) |
5.841500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.131600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.073400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.544600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.780000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.494400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.370400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.171000E-04 |
| Classical-VS-Follicular |
5.321200E-01 |
| Classical-VS-Other |
2.343800E-01 |
| Classical-VS-Normal |
3.99859999555829E-08 |
| Tall-VS-Follicular |
1.310090E-02 |
| Tall-VS-Other |
8.926100E-02 |
| Tall-VS-Normal |
7.68479724300164E-11 |
| Follicular-VS-Other |
2.028200E-01 |
| Follicular-VS-Normal |
6.15249999946776E-07 |
| Other-VS-Normal |
9.760400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.02879999975114E-07 |
| Normal-vs-N1 |
3.1742000028423E-08 |
| N0-vs-N1 |
9.339800E-02 |
|
|
